IndexIQ Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

IndexIQ Advisors’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$196K	Buy	1,257 +261	+26%	+$37.9K	0.01%	1032
2021 Q4	$127K	Sell	996 -32	-3%	-$4.21K	﹤0.01%	1065
2021 Q3	$134K	Buy	1,028 +128	+14%	+$19.3K	﹤0.01%	1072
2021 Q2	$160K	Buy	900 +35	+4%	+$6.06K	0.01%	1056
2021 Q1	$142K	Buy	865 +113	+15%	+$18.6K	0.01%	1048
2020 Q4	$124K	Buy	752 +352	+88%	+$52.4K	﹤0.01%	998
2020 Q3	$57K	Buy	400 +239	+148%	+$29.6K	﹤0.01%	979
2020 Q2	$18K	Buy	161 +142	+747%	+$15.7K	﹤0.01%	1021
2020 Q1	$2K	Sell	19 -1	-5%	-$129	﹤0.01%	961
2019 Q4	$3K	Buy	+20	New	+$2.72K	﹤0.01%	776

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

PCM

Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

IndexIQ Advisors's JAZZ Position: Q1 2022 in Review

IndexIQ Advisors increased its Jazz Pharmaceuticals (JAZZ) stake by 26% in Q1 2022, buying an estimated $37.9K and bringing the position to 1,257 shares worth $196K. The position accounts for 0.01% of the portfolio, ranked #1032.

IndexIQ Advisors first reported a position in JAZZ in Q4 2019 and has held it in 10 quarters since. 462 funds tracked by Wall St. Rank hold JAZZ as of Q1 2022.

IndexIQ Advisors held 1,257 shares of Jazz Pharmaceuticals worth $196K as of Q1 2022.
IndexIQ Advisors bought 261 Jazz Pharmaceuticals shares in Q1 2022, an estimated $37.9K.
Jazz Pharmaceuticals made up 0.01% of IndexIQ Advisors's portfolio in Q1 2022, its #1032 holding.
IndexIQ Advisors first reported a position in Jazz Pharmaceuticals in Q4 2019 and has held it in 10 quarters since.
462 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.